Martiniussen, Marit A.
Sagstad, Silje
Larsen, Marthe
Larsen, Anne Sofie F.
Hovda, Tone
Lee, Christoph I.
Hofvind, Solveig http://orcid.org/0000-0003-0178-8939
Funding for this research was provided by:
South-Eastern Norway Health Authorities and Østfold Hospital Trust
Article History
Received: 21 November 2021
Revised: 2 March 2022
Accepted: 4 March 2022
First Online: 2 April 2022
Declarations
:
: The scientific guarantor of this publication is Solveig Hofvind.
: Solveig Hofvind is the head of BreastScreen Norway. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: Two of the authors, Silje Sagstad and Marthe Larsen, have significant statistical expertise.
: Written informed consent was not required for this study because the Cancer Registry of Norway’s Regulations waive the requirement for informed consent for surveillance and quality assurance projects based on data collected as a part of invitation to and/or participation in BreastScreen Norway.
: Approval was obtained from the Oslo University Hospital data protection official for research (20/12601).
: This is a study including information from women who participated in BreastScreen Norway 2006–2019. These women are included in several other publications from BreastScreen Norway, but the specific study population used in this study has never been used for any other publication previously.
: • retrospective• cohort study• multicenter study